EVMA Conference Launch
This conference featured the presence of
Governmental Representation
The conference was honored by the presence of key governmental entities, reflecting a unified commitment to advancing vaccine manufacturing in Egypt:
- Ministry of Health and Population (MOHP)
- Egyptian Drug Authority (EDA)
- Unified Procurement Authority (UPA)
Governmental Representation
The conference was honored by the presence of key governmental entities, reflecting a unified commitment to advancing vaccine manufacturing in Egypt:
- Ministry of Health and Population (MOHP)
- Egyptian Drug Authority (EDA)
- Unified Procurement Authority (UPA)
Leading Egyptian Vaccine Manufacturers
Egypt’s six prominent vaccine manufacturers presented their achievements and roles in shaping the national vaccine landscape:
- Biogeneric Pharma
- Gennvax
- GYPTO Pharma
- VACSERA
- VBC (Vaccine & Biotechnology City)
- Eva Pharma
Global Technology Transfer Partnerships
The conference showcased strategic collaborations with renowned international technology providers aimed at enhancing local vaccine production capacities. Key partners include:
- Serum Institute of India
- Sanofi Pasteur
- Biological E
- Bilthoven
- CD BIO
- Walvaxx
- Batavia
- AJ Vaccines
- Minhai
CMO Agreements
Aims of the Conference
The EVMA Launch Conference served as a platform to:
- Strengthen collaboration among governmental, industrial, and international stakeholders.
- Address key challenges and opportunities in vaccine production.
- Advance strategic public health initiatives to establish Egypt as a global leader in vaccine manufacturing.
This landmark event underscored Egypt’s commitment to innovation, collaboration, and excellence in vaccine production, paving the way for future advancements in public health.